BMS bags UK advanced melanoma win for Opdualag

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanced melanoma as part of Project Orbis.

Dec 28, 2023 - 18:00

BMS bags UK advanced melanoma win for Opdualag

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanced melanoma as part of Project Orbis.

Read the original article

Tags:

Previous Article

STAT+: 3 medtech trends to watch in 2024

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Experts fear private equity will pour gas on cardiology’s overuse problem

STAT+: Experts fear private equity will pour gas on car...

Sep 12, 2023

ABBV-444 by AbbVie for Keratoconjunctivitis Sicca (Dry ...

Jul 1, 2023

Kymera’s novel MDM2 degrader granted orphan designation for AML

Kymera’s novel MDM2 degrader granted orphan designation...

Jun 23, 2023